190 related articles for article (PubMed ID: 16892042)
21. Potent anticarcinoma activity of the humanized anti-CD70 antibody h1F6 conjugated to the tubulin inhibitor auristatin via an uncleavable linker.
Oflazoglu E; Stone IJ; Gordon K; Wood CG; Repasky EA; Grewal IS; Law CL; Gerber HP
Clin Cancer Res; 2008 Oct; 14(19):6171-80. PubMed ID: 18809969
[TBL] [Abstract][Full Text] [Related]
22. Phase I dose-escalation study of SGN-75 in patients with CD70-positive relapsed/refractory non-Hodgkin lymphoma or metastatic renal cell carcinoma.
Tannir NM; Forero-Torres A; Ramchandren R; Pal SK; Ansell SM; Infante JR; de Vos S; Hamlin PA; Kim SK; Whiting NC; Gartner EM; Zhao B; Thompson JA
Invest New Drugs; 2014 Dec; 32(6):1246-57. PubMed ID: 25142258
[TBL] [Abstract][Full Text] [Related]
23. Preclinical characterization of SGN-70, a humanized antibody directed against CD70.
McEarchern JA; Smith LM; McDonagh CF; Klussman K; Gordon KA; Morris-Tilden CA; Duniho S; Ryan M; Boursalian TE; Carter PJ; Grewal IS; Law CL
Clin Cancer Res; 2008 Dec; 14(23):7763-72. PubMed ID: 19047103
[TBL] [Abstract][Full Text] [Related]
24. Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities.
McEarchern JA; Oflazoglu E; Francisco L; McDonagh CF; Gordon KA; Stone I; Klussman K; Turcott E; van Rooijen N; Carter P; Grewal IS; Wahl AF; Law CL
Blood; 2007 Feb; 109(3):1185-92. PubMed ID: 17038522
[TBL] [Abstract][Full Text] [Related]
25. Identification of CD70 as a diagnostic biomarker for clear cell renal cell carcinoma by gene expression profiling, real-time RT-PCR and immunohistochemistry.
Diegmann J; Junker K; Gerstmayer B; Bosio A; Hindermann W; Rosenhahn J; von Eggeling F
Eur J Cancer; 2005 Aug; 41(12):1794-801. PubMed ID: 16043348
[TBL] [Abstract][Full Text] [Related]
26. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo.
Chang DK; Moniz RJ; Xu Z; Sun J; Signoretti S; Zhu Q; Marasco WA
Mol Cancer; 2015 Jun; 14():119. PubMed ID: 26062742
[TBL] [Abstract][Full Text] [Related]
27. Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers.
Wang QJ; Yu Z; Hanada KI; Patel K; Kleiner D; Restifo NP; Yang JC
Clin Cancer Res; 2017 May; 23(9):2267-2276. PubMed ID: 27803044
[No Abstract] [Full Text] [Related]
28. Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75.
Ryan MC; Kostner H; Gordon KA; Duniho S; Sutherland MK; Yu C; Kim KM; Nesterova A; Anderson M; McEarchern JA; Law CL; Smith LM
Br J Cancer; 2010 Aug; 103(5):676-84. PubMed ID: 20664585
[TBL] [Abstract][Full Text] [Related]
29. Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.
Ortiz-Cuaran S; Swalduz A; Foy JP; Marteau S; Morel AP; Fauvet F; De Souza G; Michon L; Boussageon M; Gadot N; Godefroy M; Léon S; Tortereau A; Mourksi NE; Leonce C; Albaret MA; Dongre A; Vanbervliet B; Robert M; Tonon L; Pommier RM; Hofman V; Attignon V; Boyault S; Audoynaud C; Auclair J; Bouquet F; Wang Q; Ménétrier-Caux C; Pérol M; Caux C; Hofman P; Lantuejoul S; Puisieux A; Saintigny P
Eur J Cancer; 2022 Jul; 169():106-122. PubMed ID: 35550950
[TBL] [Abstract][Full Text] [Related]
30. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1.
Zhao M; Wu X; Zhang Q; Luo S; Liang G; Su Y; Tan Y; Lu Q
Arthritis Res Ther; 2010; 12(6):R227. PubMed ID: 21192791
[TBL] [Abstract][Full Text] [Related]
31. CD70-restricted specific activation of TRAILR1 or TRAILR2 using scFv-targeted TRAIL mutants.
Trebing J; El-Mesery M; Schäfer V; Weisenberger D; Siegmund D; Silence K; Wajant H
Cell Death Dis; 2014 Jan; 5(1):e1035. PubMed ID: 24481449
[TBL] [Abstract][Full Text] [Related]
32. Tumor associated CD70 expression is involved in promoting tumor migration and macrophage infiltration in GBM.
Ge H; Mu L; Jin L; Yang C; Chang YE; Long Y; DeLeon G; Deleyrolle L; Mitchell DA; Kubilis PS; Lu D; Qi J; Gu Y; Lin Z; Huang J
Int J Cancer; 2017 Oct; 141(7):1434-1444. PubMed ID: 28612394
[TBL] [Abstract][Full Text] [Related]
33. Expression of CD70 in nasal natural killer/T cell lymphoma cell lines and patients; its role for cell proliferation through binding to soluble CD27.
Yoshino K; Kishibe K; Nagato T; Ueda S; Komabayashi Y; Takahara M; Harabuchi Y
Br J Haematol; 2013 Feb; 160(3):331-42. PubMed ID: 23206232
[TBL] [Abstract][Full Text] [Related]
34. The down-regulation of hsa_circ_0012919, the sponge for
Zhang C; Wang X; Chen Y; Wu Z; Zhang C; Shi W
Clin Sci (Lond); 2018 Nov; 132(21):2285-2298. PubMed ID: 30237316
[TBL] [Abstract][Full Text] [Related]
35. CD70 antibody-drug conjugate: A potential novel therapeutic agent for ovarian cancer.
Shiomi M; Matsuzaki S; Serada S; Matsuo K; Mizuta-Odani C; Jitsumori M; Nakae R; Matsuzaki S; Nakagawa S; Hiramatsu K; Miyoshi A; Kobayashi E; Kimura T; Ueda Y; Yoshino K; Naka T; Kimura T
Cancer Sci; 2021 Sep; 112(9):3655-3668. PubMed ID: 34117815
[TBL] [Abstract][Full Text] [Related]
36. Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function.
Leigh ND; O'Neill RE; Du W; Chen C; Qiu J; Ashwell JD; McCarthy PL; Chen GL; Cao X
J Immunol; 2017 Jul; 199(1):336-347. PubMed ID: 28550198
[TBL] [Abstract][Full Text] [Related]
37. The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.
Li S; Chen D; Guo H; Liu D; Yang C; Zhang R; Wang T; Zhang F; Bai X; Yang Y; Sun N; Zhang W; Zhang L; Zhao G; Peng L; Tu X; Tian W
Front Oncol; 2023; 13():1240061. PubMed ID: 37849799
[TBL] [Abstract][Full Text] [Related]
38. Chronic CD70-driven costimulation impairs IgG responses by instructing T cells to inhibit germinal center B cell formation through FasL-Fas interactions.
Beishuizen CR; Kragten NA; Boon L; Nolte MA; van Lier RA; van Gisbergen KP
J Immunol; 2009 Nov; 183(10):6442-51. PubMed ID: 19864607
[TBL] [Abstract][Full Text] [Related]
39. Defective infiltration of natural killer cells in MICA/B-positive renal cell carcinoma involves beta(2)-integrin-mediated interaction.
Sconocchia G; Spagnoli GC; Del Principe D; Ferrone S; Anselmi M; Wongsena W; Cervelli V; Schultz-Thater E; Wyler S; Carafa V; Moch H; Terracciano L; Tornillo L
Neoplasia; 2009 Jul; 11(7):662-71. PubMed ID: 19568411
[TBL] [Abstract][Full Text] [Related]
40. Costimulatory ligand CD70 allows induction of CD8+ T-cell immunity by immature dendritic cells in a vaccination setting.
Keller AM; Xiao Y; Peperzak V; Naik SH; Borst J
Blood; 2009 May; 113(21):5167-75. PubMed ID: 19279334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]